Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 Sep;16(3):366–371. doi: 10.1128/aac.16.3.366

Anaerobic infection in cancer patients: comparative evaluation of clindamycin and cefoxitin.

J Klastersky, L Coppens, G Mombelli
PMCID: PMC352862  PMID: 507792

Abstract

Clindamycin and cefoxitin with or without gentamicin were administered to cancer patients having localized infections presumably caused by anaerobic pathogens. The rates of favorable response were 89% in patients receiving clindamycine alone and 78% in patients receiving cefoxitin alone. When the total experience is considered (clindamycin or cefoxitin with and without gentamicin), 20 of 24 patients (83%) responded to clindamycin and 18 of 22 (82%) responded to cefoxitin. Both therapies were well tolerated. Clindamycin was found to be more effective than cefoxitin in eradicating the offending anaerobic pathogens from the site of infection. Aerobic pathogens were frequently isolated along with anaerobes from the infectious sites in this series; their susceptibility or resistance to clindamycin or cefoxitin did not influence the therapeutic response.

Full text

PDF
366

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett J. G., Sutter V. L., Finegold S. M. Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med. 1972 Nov 16;287(20):1006–1010. doi: 10.1056/NEJM197211162872002. [DOI] [PubMed] [Google Scholar]
  2. Brumfitt W., Kosmidis J., Hamilton-Miller J. M., Gilchrist J. N. Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology. Antimicrob Agents Chemother. 1974 Sep;6(3):290–299. doi: 10.1128/aac.6.3.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Felner J. M., Dowell V. R., Jr "Bacteroides" bacteremia. Am J Med. 1971 Jun;50(6):787–796. doi: 10.1016/0002-9343(71)90187-2. [DOI] [PubMed] [Google Scholar]
  4. Henderson D. K., Chow A. W., Guze L. B. Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents. Antimicrob Agents Chemother. 1977 Apr;11(4):679–682. doi: 10.1128/aac.11.4.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Heseltine P. N., Busch D. F., Meyer R. D., Finegold S. M. Cefoxitin: clinical evaluation in thirty-eight patients. Antimicrob Agents Chemother. 1977 Mar;11(3):427–434. doi: 10.1128/aac.11.3.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Klastersky J., Husson M., Weerts-Ruhl D., Daneau D. Anaerobic wound infections in cancer patients: comparative trial of clindamycin, tinidazole, and doxycycline. Antimicrob Agents Chemother. 1977 Nov;12(5):563–570. doi: 10.1128/aac.12.5.563. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES